contezolid
Commercial- Indications
- Multi-drug resistant Gram-positive bacterial infections, Drug-resistant tuberculosis
Company intelligence / Profile preview
Shanghai Mengke Pharmaceutical Co., Ltd.
Shanghai City / Pudong New Area ("China (Shanghai) Pilot Free Trade Zone"), Shanghai Shi / Municipality directly under central government control ("Shanghai"), Chinacbinsights.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Mengke Pharmaceutical has commercialized Contizole tablets, a next-generation oxazolidinone antibiotic for drug-resistant bacterial infections. The company achieved record sales in over five hundred hospitals across China in the past year. Its R&D pipeline includes several novel antibiotics at various clinical stages targeting acute/chronic bacterial infections and nontuberculous mycobacterial diseases. MRX‑4 completed Phase III trials with positive results; MRX‑5 and MRX‑8 are advancing through early-stage clinical development internationally.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecules (notably oxazolidinone antibiotics, benzoxaborole antibiotics)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Joint venture with MicuRx Pharmaceuticals Inc.Investment from Shanghai Zhangjiang Biomedical Industry Venture Capital
Beyond the preview
Go deeper on Shanghai Mengke Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Mengke Pharmaceutical Co., Ltd..